OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
1718$6.5057

China Man-Made Fiber Corp

Commodity ChemicalsVerified

China Man-Made Fiber Corp has a liquidity profile that is constrained by its high debt-to-equity ratio of 41.97 and a current ratio of 0.86, indicating that its short-term liabilities exceed its short-term assets. The company's cash and equivalents of TWD 59,997.7 million are insufficient to cover its long-term debt of TWD 922,199.4 million, resulting in a negative net cash position after subtracting total debt. The price-to-book ratio of 0.39 suggests that the company's market value is significantly below its book value, which may reflect concerns about its asset quality or future earnings potential. The company's profitability is weak, with a return on equity (ROE) of 0.0054 and a return on assets (ROA) of 0.0001, both of which are far below the typical thresholds for healthy performance in the Commodity Chemicals industry. Despite a gross profit of TWD 32,148.95 million, the net income of TWD 118.83 million is minimal, indicating that the company is struggling to convert its gross profits into net earnings. This underperformance is likely due to high operating costs and a competitive pricing environment in the chemical products market. The company's revenue is concentrated in the domestic market and Asian markets, with no disclosed breakdown of segment or geographic contributions. This lack of diversification increases its exposure to regional economic fluctuations and regulatory changes. The absence of detailed segment data makes it difficult to assess the performance of its petrochemical, commercial banking, and general investment businesses, which are operated through subsidiaries. The company's growth trajectory is uncertain, with no disclosed revenue growth rates or future projections. The operating cash flow of TWD 3,373.64 million and free cash flow of TWD 528.09 million are modest, limiting the company's ability to reinvest in its operations or reduce its debt burden. The capital expenditure of TWD -2,801.19 million suggests that the company is not actively investing in new projects or capacity expansion, which could hinder its long-term growth prospects. The company faces significant liquidity and dilution risks. The liquidity risk is rated as medium, with the key flag being a negative net cash position after subtracting total debt. The dilution risk is rated as low, but the company's high debt-to-equity ratio and limited free cash flow could lead to future equity issuances to service its debt. The risk assessment does not mention any specific dilution sources, but the company's financial structure suggests that it may need to raise additional capital in the near term. Recent events and filings do not provide specific details about the company's strategic initiatives or operational changes. The company's financial performance and risk profile suggest that it is facing challenges in maintaining profitability and liquidity. The lack of detailed segment and geographic data limits the ability to assess the company's exposure to different markets and the effectiveness of its diversification strategy.

30-day price · 1718-0.86 (-11.7%)
Low$6.25High$7.40Close$6.47As of22 May, 00:00 UTC
Profile
CompanyChina Man-Made Fiber Corp
Ticker1718.TW
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. China Man-Made Fiber Corp is a Taiwan-based manufacturer and distributor of chemical products and chemical fiber products, including monoethylene glycol (MEG), diethylene glycol (DEG), triethylene glycol (TEG), ethylene oxide (EO), nonyl phenol (NP), polyester filaments, and polyester chips, used in the production of garments, cloths, and footwear materials.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

China Man-Made Fiber Corp has a liquidity profile that is constrained by its high debt-to-equity ratio of 41.97 and a current ratio of 0.86, indicating that its short-term liabilities exceed its short-term assets. The company's cash and equivalents of TWD 59,997.7 million are insufficient to cover its long-term debt of TWD 922,199.4 million, resulting in a negative net cash position after subtracting total debt. The price-to-book ratio of 0.39 suggests that the company's market value is significantly below its book value, which may reflect concerns about its asset quality or future earnings potential. The company's profitability is weak, with a return on equity (ROE) of 0.0054 and a return on assets (ROA) of 0.0001, both of which are far below the typical thresholds for healthy performance in the Commodity Chemicals industry. Despite a gross profit of TWD 32,148.95 million, the net income of TWD 118.83 million is minimal, indicating that the company is struggling to convert its gross profits into net earnings. This underperformance is likely due to high operating costs and a competitive pricing environment in the chemical products market. The company's revenue is concentrated in the domestic market and Asian markets, with no disclosed breakdown of segment or geographic contributions. This lack of diversification increases its exposure to regional economic fluctuations and regulatory changes. The absence of detailed segment data makes it difficult to assess the performance of its petrochemical, commercial banking, and general investment businesses, which are operated through subsidiaries. The company's growth trajectory is uncertain, with no disclosed revenue growth rates or future projections. The operating cash flow of TWD 3,373.64 million and free cash flow of TWD 528.09 million are modest, limiting the company's ability to reinvest in its operations or reduce its debt burden. The capital expenditure of TWD -2,801.19 million suggests that the company is not actively investing in new projects or capacity expansion, which could hinder its long-term growth prospects. The company faces significant liquidity and dilution risks. The liquidity risk is rated as medium, with the key flag being a negative net cash position after subtracting total debt. The dilution risk is rated as low, but the company's high debt-to-equity ratio and limited free cash flow could lead to future equity issuances to service its debt. The risk assessment does not mention any specific dilution sources, but the company's financial structure suggests that it may need to raise additional capital in the near term. Recent events and filings do not provide specific details about the company's strategic initiatives or operational changes. The company's financial performance and risk profile suggest that it is facing challenges in maintaining profitability and liquidity. The lack of detailed segment and geographic data limits the ability to assess the company's exposure to different markets and the effectiveness of its diversification strategy.
Key takeaways
  • The company has a high debt-to-equity ratio of 41.97 and a current ratio of 0.86, indicating significant liquidity constraints.
  • The company's profitability is weak, with a return on equity of 0.0054 and a return on assets of 0.0001.
  • The company's revenue is concentrated in the domestic market and Asian markets, increasing its exposure to regional economic fluctuations.
  • The company's growth trajectory is uncertain, with limited operating and free cash flows and no active capital expenditures.
  • The company faces liquidity risks due to a negative net cash position after subtracting total debt.
  • The company's financial performance and risk profile suggest that it is facing challenges in maintaining profitability and liquidity.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$42.73B
Gross profit$32.15B
Operating income$20.88B
Net income$118.8M
R&D
SG&A
D&A
SBC
Operating cash flow$3.37B
CapEx-$2.80B
Free cash flow$5.28B
Total assets$1.04T
Total liabilities$1.02T
Total equity$21.98B
Cash & equivalents$60.00B
Long-term debt$922.20B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$6.50
Market cap$8.67B
Enterprise value$870.87B
P/E73.0
Reported non-GAAP P/E
EV/Revenue20.4
EV/Op income41.7
EV/OCF258.1
P/B0.4
P/Tangible book0.4
Tangible book$21.98B
Net cash-$862.20B
Current ratio0.9
Debt/Equity42.0
ROA0.0%
ROE0.5%
Cash conversion28.4%
CapEx/Revenue-6.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric1718Activity
Op margin48.9%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin0.3%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin75.2%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-6.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity4197.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 10:32 UTC#9413f8eb
Market quoteclose TWD 6.50 · shares 1.33B diluted
no public URL
2026-05-04 11:32 UTC#285c2ae2
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 11:33 UTCJob: 196057eb